← Evidence map

ArticleFrontiers in cardiovascular medicine2020

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction.

Ayman Ibrahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33426003